1192454-69-5

Basic information

• Product Name: [3-(3-tert-butoxycarbonylamino-phenoxy)-2-cyano-5-fluoro-phenyl]-(2-fluoro-4-iodo-phenyl)-carbamic acid tert-butyl ester
• Synonyms: [3-(3-tert-butoxycarbonylamino-phenoxy)-2-cyano-5-fluoro-phenyl]-(2-fluoro-4-iodo-phenyl)-carbamic acid tert-butyl ester
• CAS NO: 1192454-69-5
• Molecular Weight: 663.46
• Mol File: 1192454-69-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: [3-(3-tert-butoxycarbonylamino-phenoxy)-2-cyano-5-fluoro-phenyl]-(2-fluoro-4-iodo-phenyl)-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(3-tert-butoxycarbonylamino-phenoxy)-2-cyano-5-fluoro-phenyl]-(2-fluoro-4-iodo-phenyl)-carbamic acid tert-butyl ester(1192454-69-5)
• EPA Substance Registry System: [3-(3-tert-butoxycarbonylamino-phenoxy)-2-cyano-5-fluoro-phenyl]-(2-fluoro-4-iodo-phenyl)-carbamic acid tert-butyl ester(1192454-69-5)

Safety Data

• Hazardous Substances Data: 1192454-69-5(Hazardous Substances Data)

Upstream product

• 1084333-49-2 2,4-difluoro-6-(2-fluoro-4-iodo-phenylamino)-benzonitrile 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1084333-50-5 2-(2-cyano-3,5-difluoro-phenyl)-(2-fluoro-4-iodo-phenyl)-carbamic acid tert-butyl ester 
• 19962-06-2 tert-butyl 3-hydroxyphenylcarbamate 

Downstream Products

• 1084332-21-7 2-(3-amino-phenoxy)-4-fluoro-6-(2-fluoro-4-iodo-phenylamino)-benzamide 
• 1192454-70-8 2-(3-amino-phenoxy)-4-fluoro-6-(2-fluoro-4-iodo-phenylamino)-benzonitrile 
• 1226784-86-6 4-fluoro-2-(2-fluoro-4-iodo-phenylamino)-6-[3-(propane-2-sulfonylamino)-phenoxy]-benzamide 
• 1226784-85-5 2-(3-ethanesulfonylamino-phenoxy)-4-fluoro-6-(2-fluoro-4-iodo-phenylamino)-benzamide 

Relevant articles and documents

SUBSTITUTED SULPHONAMIDO PHENOXYBENZAMIDES

The present invention relates to substituted sulphonamido phenoxybenzamide compounds of general formula (I) in which A, R1, R2, R3, R4, R5, R6, R7, R8 and n are as defined in the claims, to pharmaceutical compositions and combinations containaining said compounds, to methods of preparing said compounds, and to the use of said compounds or compositions for treating hyper- proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.